These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Prevention with gamma globulin of Rh isoimmunization: current problems. Review]. Spensieri S; Carnevale-Arella E Riv Ostet Ginecol; 1968 Nov; 23(11):792-800. PubMed ID: 4187892 [No Abstract] [Full Text] [Related]
23. [Study of plasmas with reference to their selection for the preparation of anti-Rh gamma globulins for the prevention of Rh iso-immunization]. Cregut R; Pinon F; Poulain M; André R Rev Fr Transfus; 1969; 12(1):Suppl:331-9. PubMed ID: 4195087 [No Abstract] [Full Text] [Related]
24. The prevention of rhesus disease. Midwife Health Visit Community Nurse; 1979 Aug; 15(8):299. PubMed ID: 89617 [No Abstract] [Full Text] [Related]
25. Anti-Rh globulin in Massachusetts. Edsall G N Engl J Med; 1969 Feb; 280(7):386-7. PubMed ID: 4178642 [No Abstract] [Full Text] [Related]
26. [Present status of anti Rh isoimmunization. General review]. Mateu-Aragones JM Acta Obstet Ginecol Hisp Lusit; 1968; 16(1):52-78. PubMed ID: 4190331 [No Abstract] [Full Text] [Related]
28. [Prevention of fetal Rh erythroblastosis]. Benoit P Union Med Can; 1969 May; 98(5):753-6. PubMed ID: 4097154 [No Abstract] [Full Text] [Related]
29. Prevention of Rh hemolytic disease of the newborn. Jennings ER; Dibbern HH; Hodell FH; Monroe CH; Peckham NH; Sullivan JF; Pollack W Calif Med; 1969 Feb; 110(2):130-3. PubMed ID: 4181977 [TBL] [Abstract][Full Text] [Related]
30. Advances in prophylaxis and therapy of Rh-erythroblastosis. Thomsen K Nihon Sanka Fujinka Gakkai Zasshi; 1969 Aug; 21(8):911-2. PubMed ID: 4186822 [No Abstract] [Full Text] [Related]
31. [Experience with finding women with indication for the administration of anti-D gamma globulin]. Skácel K Cesk Gynekol; 1969 Oct; 34(8):473-4. PubMed ID: 4187683 [No Abstract] [Full Text] [Related]
32. [Use of anti-D gamma globulins in the prevention of Rh isoimmunization]. Gasparri F; Massi GB; Curiel P; Cattaneo A Boll Soc Ital Biol Sper; 1968 Nov; 44(22):1881-4. PubMed ID: 4186556 [No Abstract] [Full Text] [Related]
34. [Serological prophylaxis of Rh-hemolytic disease]. Nordhagen R Tidsskr Nor Laegeforen; 1967 Sep; 87(18):Suppl:1577-81. PubMed ID: 4173304 [No Abstract] [Full Text] [Related]
35. Prevention of Rh-haemolytic disease--1969. Med J Aust; 1969 May; 1(20):1035-6. PubMed ID: 4182380 [No Abstract] [Full Text] [Related]
36. [Clinical aspects in the prevention of antibody formation with anti-D-immunoglobulin]. Frey P; Hinselmann M; Hindemann P Gynaecologia; 1969; 167(5):280-4. PubMed ID: 4184764 [No Abstract] [Full Text] [Related]
37. [Use of immunoglobulin anti-Rh for the prevention of hemolytic disease of the newborn]. Wald U; Nelken D Harefuah; 1971 Jan; 80(1):4-6. PubMed ID: 4104280 [No Abstract] [Full Text] [Related]
38. [Management of Rh prophylaxis]. Sljapić N; Suvaković D; Bregun-Dragić N; Kuzmancev O; Djordjević M Med Pregl; 1979; 32(7-8):367-70. PubMed ID: 93239 [No Abstract] [Full Text] [Related]
39. [Status of Rh sensitization prevention in the Federal Republic of Germany]. Stolp W; Schlenter W; Schneider J Geburtshilfe Frauenheilkd; 1972 Sep; 32(9):762-72. PubMed ID: 4116752 [No Abstract] [Full Text] [Related]
40. New method for control of immunologic problems from the Rh-incompatible pregnancy. White CA J Iowa Med Soc; 1970 Jan; 60(1):13-5. PubMed ID: 4189233 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]